Skip to content
DataLookout
Menu

Ulcerative Colitis clinical trials

Get alerts when Ulcerative Colitis trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22

What changed in the last 30 days

54 trials changed in the last 30 days: 0 stopped, 20 with notable changes, 34 with minor changes only.

  1. Notable: MFI · Modafinil For Fatigue in IBD Recruitment opened Imperial College LondonPhase 2 NCT07295834
  2. Minor: Feels-Mici · Analysis of Barriers and Facilitators to Adapted Physical Activity · Chronic Inflammatory Bowel Diseases Trial completed Fondation LenvalNot specified NCT07383844
  3. Minor: SUNSCAPE-1 · Induction Study to Investigate the Efficacy and Safety of Duvakitug · Moderately to Severely Active Ulcerative Colitis Trial sites expanded: 240 → 265 locations SanofiPhase 3 NCT07184996
  4. Notable: VR Therapies for IBD Enrolling by invitation only Brennan SpiegelNot applicable NCT07590518
  5. Minor: COLOR UC · Brivekimig · Ulcerative Colitis Trial sites reduced: 69 → 61 locations SanofiPhase 2 NCT06975722
  6. Minor: Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Study completion pushed from Nov 30, 2026 to May 1, 2027 Northwestern UniversityPhase 2 NCT04767984
  7. Minor: EcoVitis · Procyanidins in Leaky Gut Repairing in IBD Trial status changed: Unknown → Completed University of PadovaNot applicable NCT06576700
  8. Minor: SKYLINE-UC · Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis Trial sites expanded: 276 → 279 locations Spyre Therapeutics, Inc.Phase 2 NCT07012395
  9. Notable: Online Pain Education for Crohn's Disease and Ulcerative Colitis Enrolling by invitation only Cedars-Sinai Medical CenterNot applicable NCT07671313
  10. Minor: ENDEAVOUR-UC · Etrasimod · Moderate to Severe Ulcerative Colitis Enrollment closed, study ongoing PfizerNot specified NCT06398626
  11. Minor: PAFIT-IBD · Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease Trial completed Universidad Complutense de MadridNot applicable NCT07484620
  12. Notable: PROMPT-IBD · PROactive and Early Infliximab Monitoring and oPTimization in Inflammatory Bowel Disease Primary completion pushed from Jan 2026 to Mar 2027 Pontificia Universidad Catolica de ChileNot applicable NCT06758024
  13. Notable: IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) Recruitment opened Nanjing Immunophage Biotech Co., LtdPhase 2 NCT07535489
  14. Minor: MK-8690 · Moderately to Severely Active Ulcerative Colitis (MK-8690-002) Trial sites expanded: 38 → 43 locations Merck Sharp & Dohme LLCPhase 2 NCT07463183
  15. Minor: SECURITY · Remote Monitoring Application in the Follow-up · Active Inflammatory Bowel Diseases Enrollment closed, study ongoing Groupe d'Etude Therapeutique des Affections Inflammatoires DigestivesNot applicable NCT06742385
  16. Minor: Longitudinal Immunophenotyping · Inflammatory Bowel Disease Start date changed from estimate of Nov 12, 2026 to Nov 5, 2026 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not specified NCT07619547
  17. Notable: Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis Recruitment opened Tanta UniversityPhase 2/3 NCT07820046
  18. Minor: Microbiome-targeted Diet Therapy in Ulcerative Colitis Start date moved earlier from Nov 9, 2026 to Nov 4, 2026 University of MinnesotaNot applicable NCT07520461
  19. Minor: 7 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep7 trials
    1. Minor: QUANTUM · Quest to Analyze One Thousand Humans Meditating Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation Tobias Moeller-BertramNot specified NCT06583395
    2. Minor: Zuoqing SAN in Treating Ulcerative Colitis Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting The Second Affiliated Hospital of Anhui University of Traditional Chinese MedicinePhase 1/2 NCT06667934
    3. Minor: TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Post Graduate Institute of Medical Education and Research, ChandigarhPhase 4 NCT06625450
    4. Minor: CSRRUC · Critical State of "Remission-Recurrence" of Ulcerative Colitis Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Beijing Hospital of Traditional Chinese MedicineNot specified NCT06694883
    5. Minor: ProZ-UC · ProLife 10 FORTE on Gut Microbiota Composition in UC Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting University of PadovaNot applicable NCT06642883
    6. Minor: CONF-UC · Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting FEDERICA FURFARONot applicable NCT06624579
    7. Minor: Acupuncture for Symptom Relief · Mild to Moderate Ulcerative Colitis Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting Guang'anmen Hospital of China Academy of Chinese Medical SciencesNot applicable NCT06615765
  20. Notable: MOVE-IT · MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease Enrolling by invitation only Odense University HospitalPhase 4 NCT06788340
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-17 NCT07941921 Urgency in UC Patients With or Without Mucosal Healing Gerhard Rogler new
2026-11-12 NCT07932691 Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative… Beijing VDJBio Co., LTD. new Phase 1
2026-11-04 NCT07916493 Effects of Different Physical Activity Strategies on Disease Activity of IBD Patients Szeged University new
2026-11-03 NCT07913347 Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT… Metagen Therapeutics, Inc. new Phase 1/2
2026-10-28 NCT07900945 Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants Keymed Biosciences Co.Ltd new Phase 1
2026-10-09 NCT07869225 A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of EQ504 in Single and… Equillium new Phase 1
2026-10-05 NCT07857447 The Effects of a Modified Mediterranean Diet on Ulcerative Colitis Patients University Hospital Sestre Milosrdnice new
2026-09-30 NCT07848737 A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With… Janssen-Cilag, S.A. new
2026-09-22 NCT07834515 Phase 1b Clinical Study in Patients With Active Ulcerative Colitis Thetis Pharmaceuticals LLC new Phase 1
2026-09-18 NCT07828886 Immune Aging and Advanced Therapy Outcomes in Older Adults With IBD First Affiliated Hospital, Sun Yat-Sen University new

Active trials by phase

Early Phase 1
8
Phase 1
29
Phase 1/2
11
Phase 2
72
Phase 2/3
7
Phase 3
39
Phase 4
38
Not charted: 290 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when Ulcerative Colitis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free